While patient engagement from early development through market access to patient access is becoming more and more a standard in the pharmaceutical industry, it is even more important in cell-, gene, and organ replacement therapies (so-called ATMPs).
admedicum, together with friends (family, collaborators, clients), participated in the 2nd edition of the Rare Diseases Run in Aachen, Amsterdam, and Cologne.
Listen to Thomas Smith, Life Sciences Public Engagement Specialist, and Dr. Andreas Reimann, Managing Partner and Co-Founder of admedicum discussing patient engagement in Health Technology Assessment (HTA) processes. Their conversation focused on how patients can interact at the right time with HTA processes to ensure the patients’ best interests are covered in areas like patient-relevant data, access to new treatments, and affordability.
More than fifty participants responded to the invitation of admedicum and the French patient organizations Corasso and Seintinelles, and gathered at the Cité Internationale Universitaire de Paris for this first Patient Engagement Meetup in the city, “les Rencontres de l’Engagement Patient“.
We are very pleased to welcome Tiziana Scanu as Patient Engagement Manager.
At the beginning of this year, we took the time once more to reflect on our major learnings and most inspiring experiences from a selection of meetings and conferences in 2022 which will serve as an inspiration moving forward on the right path in 2023.
patient2care is a knowledge platform developed through co-creation with & for patients.
More than one-third of clinical trial budgets is spent on recruitment and about one-third of the trials are ultimately cancelled due to insufficient participation.
"Patients on the Move!" is a brand-new podcast about Patient Engagement in Life Sciences by admedicum – PATIENT DRIVEN SOLUTIONS.
